News
Usnoflast is an orally available small molecule that's designed to reduce inflammation, a key contributor to nerve cell ...
2d
MedPage Today on MSNSome Psych Meds Tied to Higher Future Risk of ALSPrescribed use of anti-anxiety drugs, hypnotics and sedatives, or antidepressants was tied to a higher future risk of ...
Corcept Therapeutics has tried to cast its recent phase 2 amyotrophic lateral sclerosis (ALS) failure in a more flattering ...
2d
Worcester Telegram on MSN'I miss her deeply': Clark University professor and 'Hometown Hero' Amy Richter diesAmy Richter, the chairwoman of the Clark University History Department who was recognized as a "Hometown Hero" by Worcester ...
Corcept Therapeutics Incorporated (NASDAQ:CORT) said on Thursday that it presented results from its Phase 2 DAZALS study of ...
Analysts at Truist Securities called the mid-stage data a "mixed bag," also flagging gastrointestinal adverse events. However ...
7d
Pets Radar on MSNVet shares 4 reasons why dog owners should not take part in the ‘harmless’ viral canine ice bucket challengeWe’re all familiar with the ice bucket challenge, which became a huge viral event in 2014 with the aim of raising awareness ...
It’s been nearly a year since Charlottesville lost one of its most respected pediatricians. At 65, he was diagnosed with a ...
Amyotrophic lateral sclerosis (ALS) is a progressive disease that causes severe weakness due to progressive degeneration of a specific set of motor nerves in the spinal cord. People with ALS will ...
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results